← Pharming Group N.V.

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Net Income — — — — — $13.7m ($10.5m) ($11.8m) $2.9m
Net Income From Continuing Operations — — — — — $15.0m ($12.0m) ($8.5m) $12.8m
Other Adjustments To Reconcile Profit Loss — — ($39k) ($1.4m) $524k ($1.6m) ($1.1m) $0 $0
Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss — — $5.2m $7.3m $19.6m $13.2m $15.9m $16.1m $11.2m
Depreciation, amortization, impairment of non-current assets — $6.6m $5.2m $7.3m $19.6m $13.2m $15.9m $16.1m $11.2m
Depreciation — — — — — $13.2m $15.9m $16.1m $11.2m
Depreciation Amortization Depletion — — — — — $13.2m $15.9m $16.1m $11.2m
Adjustments For Deferred Tax Of Prior Periods — — ($373k) ($3.0m) ($1.1m) $124k $73k $1.8m ($334k)
Adjustments For Share-Based Payments — — $3.8m $5.7m $9.1m $6.4m $9.3m $11.2m $13.8m
Exercise of share-based compensation awards — $10.5m $2.8m $2.4m $4.7m $2.3m $8.1m $5.6m $19.8m
Share of net losses (gains) in associates using the equity method — $0 ($229k) ($317k) ($694k) $1.1m $289k $1.8m ($623k)
Investment accounted for using the equity method — $0 ($2.5m) ($288k) $0 — $0 $0 ($739k)
Earnings (Loss)es From Equity Investments — — — — — $1.1m $289k $1.8m ($623k)
Total changes in working capital — ($4.8m) $721k ($2.6m) ($5.0m) ($387k) ($17.0m) ($10.1m) $10.4m
Additional Financial Items
Adjustments For Current Tax Of Prior Period — — ($242k) ($1.3m) ($96k) $9k ($241k) ($315k) $765k
Adjustments For Finance Costs — — $15.3m $29.2m $6.2m $5.5m $9.1m $9.9m $17.9m
Adjustments For Finance Income — — $1.0m $624k $14.9m $4.5m $3.7m $6.8m $2.2m
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates — — — — — $12.2m $0 $0 —
General And Administrative Expense — — $18.9m $21.1m $37.0m $46.0m $55.9m $70.7m $80.0m
Increase Decrease In Working Capital — — ($721k) $2.6m $5.0m $387k $17.0m $10.1m ($10.4m)
Interest Received Classified As Operating Activities — — $1.0m $626k $53k $85k $2.9m $5.2m $2.1m
Payments Of Lease Liabilities Classified As Financing Activities — — $2.0m $1.9m $3.2m $3.3m $5.1m $4.0m $4.2m
Proceeds From Borrowings Classified As Financing Activities — — — — — — — $104.5m $0
Repayments Of Borrowings Classified As Financing Activities — — $31.4m $50.1m $0 $0 — — —
Profit (loss) before tax — $857k $46.7m $38.6m $23.1m $15.0m ($12.0m) ($8.5m) $12.8m
Equity settled share based payments — $3.3m $3.8m $5.7m $9.1m $6.4m $9.3m $11.2m $13.8m
Fair value loss (gain) on revaluation — $495k $209k ($60k) ($114k) $1.2m $930k ($5.0m) ($2.3m)
Gain on disposal from PRV sale — — — — $0 $0 ($21.3m) $0 $0
Loss (gain) on disposal of leases — — — — — $0 $0 $22k ($3.7m)
Other finance income — ($18k) ($1.0m) ($624k) ($14.9m) ($4.5m) ($3.7m) ($6.8m) ($2.2m)
Other finance expenses — $36.7m $15.3m $29.2m $6.2m $5.5m $9.1m $9.9m $17.9m
Other — ($2.4m) ($39k) ($1.4m) $524k ($1.6m) ($1.1m) $0 $0
Inventories — $1.0m $3.1m ($2.8m) ($6.2m) ($15.0m) ($14.4m) ($503k) ($1.3m)
Trade and other receivables — ($6.6m) ($8.5m) ($3.5m) $5.9m $2.4m ($18.5m) ($6.8m) ($3.4m)
Payables and other current liabilities — $1.4m $8.7m $2.6m ($5.2m) $12.0m $16.2m ($2.8m) $14.1m
Provisions — — — — — — $0 $0 $1.2m
Interest received — $18k $1.0m $626k $53k $85k $2.9m $5.2m $2.1m
Proceeds from PRV sale — — — — $0 $0 $21.3m $0 $0
Investment intangible assets — ($1.3m) ($1.6m) ($7.9m) ($3.4m) ($601k) ($27k) ($6k) ($6k)
Disposal of investment designated as at FVOCI — — — — — $0 $0 $2.1m $224k
Purchases of marketable securities — — — — $0 $0 ($382.0m) ($284.3m) ($2k)
Proceeds from sale of marketable securities — — — — $0 $0 $232.8m $314.6m $85.0m
Acquisition of a subsidiary, net of cash acquired — — — — — — $0 $0 ($57.5m)
Payment of lease liabilities — $0 ($2.0m) ($1.9m) ($3.2m) ($3.3m) ($5.1m) ($4.0m) ($4.2m)
Interests on lease liabilities — — — — — $0 ($1.1m) ($1.1m) ($1.1m)
Net proceeds of issued convertible bonds — — — — — $0 $0 $104.5m $0
Repurchase of convertible bonds — ($2.3m) $0 $0 — $0 $0 ($134.9m) $0
Interests on convertible bonds — ($11.1m) ($8.4m) ($1.9m) ($4.4m) ($4.0m) ($4.0m) ($4.5m) ($5.1m)
Acquisition of non-controlling interests — — — — — — $0 $0 ($7.9m)
Beginning Cash Position — — — — — $191.9m $207.3m $61.7m $54.9m
Cash Flow From Continuing Financing Activities — — — — — ($5.0m) ($1.0m) ($34.4m) $1.5m
Cash Flow From Continuing Investing Activities — — — — — $5.3m ($129.4m) $31.6m $26.3m
Change In Inventory — — — — — ($15.0m) ($14.4m) ($503k) ($1.3m)
Change In Other Working Capital — — — — — $273k ($216k) ($17k) $902k
Change In Payable — — — — — $12.0m $16.2m ($2.8m) $14.1m
Change In Payables And Accrued Expense — — — — — $12.0m $16.2m ($2.8m) $14.1m
Change In Receivables — — — — — $2.4m ($18.5m) ($6.8m) ($3.4m)
Change In Working Capital — — — — — ($387k) ($17.0m) ($10.1m) $10.4m
Changes In Cash — — — — — $22.8m ($147.7m) ($4.6m) $82.5m
End Cash Position — — — — — $207.3m $61.7m $54.9m $145.3m
Financing Cash Flow — — — — — ($5.0m) ($1.0m) ($34.4m) $1.5m
Free Cash Flow — — — — — $20.5m ($18.8m) ($2.6m) $54.0m
Gain Loss On Investment Securities — — — — — $1.2m $930k ($5.0m) ($2.3m)
Gain Loss On Sale Of Business — — — — — ($12.2m) $0 $0 —
Gain Loss On Sale Of PPE — — — — — $0 $0 $22k —
Interest Received CFO — — — — — $85k $2.9m $5.2m $2.1m
Investing Cash Flow — — — — — $5.3m ($129.4m) $31.6m $26.3m
Issuance Of Capital Stock — — — — $4.7m $2.3m — — —
Net Business Purchase And Sale — — — — — $7.3m $0 $0 ($58.2m)
Net Intangibles Purchase And Sale — — — — — ($601k) ($27k) ($6k) ($6k)
Operating Gains Losses — — — — — ($11.2m) ($21.0m) $1.8m ($4.4m)
Other Non Cash Items — — — — — $587k $5.3m ($1.9m) $13.4m
Proceeds From Stock Option Exercised — — — — — $2.3m $8.1m $5.6m $19.8m
Purchase Of Business — — — — $0 — $0 $0 ($58.2m)
Purchase Of Intangibles — — — — — ($601k) ($27k) ($6k) ($6k)
Sale Of Business — — — — — $7.3m $0 $0 —
Stock Based Compensation — — — — — $6.4m $9.3m $11.2m $13.8m
Profit or Loss — — $36.2m $33.0m $16.0m $13.7m ($10.5m) ($11.8m) $2.5m
Capital expenditure for property, plant and equipment — ($2.5m) ($2.4m) ($4.1m) ($10.7m) ($1.4m) ($1.4m) ($790k) ($749k)
Capital Expenditure Reported — — — $4.1m $10.7m ($1.4m) ($1.4m) ($790k) ($749k)
Net Investment Purchase And Sale — — — — — $0 ($149.2m) $32.4m $85.2m
Purchase Of Investment — — — — — $0 ($382.0m) ($284.3m) ($2k)
Sale Of Investment — — — — — $0 $232.8m $316.7m $85.2m
Net Other Investing Changes — — — — — — $21.3m — ($1k)
Net cash flows generated from (used in) investing activities — ($3.8m) ($25.2m) ($13.7m) ($21.3m) $5.3m ($129.4m) $31.6m $26.3m
Issuance Of Debt — — — — — $0 $0 $104.5m $0
Long Term Debt Issuance — — — — — $0 $0 $104.5m $0
Net Issuance Payments Of Debt — — — — — ($3.3m) ($4.0m) ($34.4m) ($4.2m)
Net Long Term Debt Issuance — — — — — ($3.3m) ($4.0m) ($34.4m) ($4.2m)
Long Term Debt Payments — — — — — ($3.3m) ($4.0m) ($138.9m) ($4.2m)
Repayment Of Debt — — — — — ($3.3m) ($4.0m) ($138.9m) ($4.2m)
Common Stock Issuance — — — — $4.7m $2.3m — — —
Net Common Stock Issuance — — — — $4.7m $2.3m — — —
Cash Dividends Paid — — — — — $0 $0 $0 $0
Net Other Financing Charges — — — — ($25.0m) — — — ($7.9m)
Net cash flows generated from (used in) financing activities — ($18.0m) ($56.6m) $53.1m ($27.9m) ($5.0m) ($1.0m) ($34.4m) $1.5m
Exchange rate effects — $2.9m $1.3m ($12.6m) ($1.8m) ($7.4m) $2.1m ($2.2m) $7.9m
Effect Of Exchange Rate Changes — — — — — ($7.4m) $2.1m ($2.2m) $7.9m
Increase (decrease) of cash — $18.8m ($15.4m) $113.4m ($11.4m) $22.8m ($147.7m) ($4.6m) $82.5m
Restricted cash — $132k ($1.1m) $1.0m $467k $273k ($216k) ($17k) ($285k)
Cash and cash equivalents at beginning of period $58.7m $80.3m $66.3m $167.1m $191.9m $207.3m $61.7m $54.9m $145.3m
Change In Cash Supplemental As Reported — — — — — $22.8m ($147.7m) ($4.6m) $82.5m
Interest Paid Classified As Financing Activities — — $8.4m $1.9m $4.4m $4.0m $4.0m $4.5m $5.1m
Income Taxes Paid Refund Classified As Operating Activities — ($1.4m) $5.1m $2.3m $0 $1.2m $655k $15.6m $4.6m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.